Safety study of a single dose of SYH2082 in healthy volunteers
Part of Hormones & metabolism clinical trials.
This study tests a new injection called SYH2082 in healthy volunteers to see how the body handles it and what side effects might occur. It is an early-stage trial that may help in developing a treatment for weight-related conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- Your weight should be stable (no change of more than 5%) for the last 3 months.
- You cannot have diabetes or a history of high blood sugar.
- You must not have thyroid nodules, medullary thyroid cancer, or a family history of these conditions.
- You must not have used weight-loss drugs (like GLP-1) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injected medicine called SYH2092 in healthy adults. It aims to see how safe it is and how the body handles it, which could help develop a future treatment for conditions like diabetes or obesity.
This study tests an investigational injection called SYH2069 for weight loss in people who are obese but do not have diabetes. It aims to see if the drug is safe and helps reduce body weight.
This study tests a new medication called SYH9017 for people who are overweight or have obesity. It aims to see how safe the drug is, how well it is tolerated, and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.
This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.
This trial tests an investigational injection called SYH2062 in healthy adults to see if it's safe. It helps researchers understand how the drug affects the body before testing in patients.
This study tests a new injection called SYH2070 for people with high triglycerides and high LDL cholesterol. The goal is to see if a single dose is safe and how the body processes the medication. It is for people who have not been on cholesterol-lowering drugs recently.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.